State of Wisconsin Investment Board’s Foghorn Therapeutics FHTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$314K Buy
65,645
+12,501
+24% +$68.6K ﹤0.01% 2198
2025
Q4
$287K Sell
53,144
-18,500
-26% -$83.9K ﹤0.01% 2179
2025
Q3
$350K Buy
71,644
+10,100
+16% +$53.6K ﹤0.01% 2046
2025
Q2
$289K Hold
61,544
﹤0.01% 2073
2025
Q1
$225K Buy
61,544
+20,400
+50% +$93K ﹤0.01% 2081
2024
Q4
$194K Buy
41,144
+24,200
+143% +$176K ﹤0.01% 2141
2024
Q3
$158K Buy
+16,944
New +$123K ﹤0.01% 2182
2022
Q2
Sell
-26,000
Closed -$396K 2836
2022
Q1
$396K Hold
26,000
﹤0.01% 2016
2021
Q4
$595K Buy
+26,000
New +$374K ﹤0.01% 1625

Other funds holding FHTX

State of Wisconsin Investment Board's FHTX Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Foghorn Therapeutics (FHTX) stake by 24% in Q1 2026, buying an estimated $68.6K and bringing the position to 65,645 shares worth $314K. The position accounts for ﹤0.01% of the portfolio, ranked #2198.

State of Wisconsin Investment Board first reported a position in FHTX in Q4 2021 and has held it in 9 quarters since. The position peaked at $595K in Q4 2021. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • State of Wisconsin Investment Board held 65,645 shares of Foghorn Therapeutics worth $314K as of Q1 2026.
  • State of Wisconsin Investment Board bought 12,501 Foghorn Therapeutics shares in Q1 2026, an estimated $68.6K.
  • Foghorn Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #2198 holding.
  • State of Wisconsin Investment Board first reported a position in Foghorn Therapeutics in Q4 2021 and has held it in 9 quarters since.
  • State of Wisconsin Investment Board's Foghorn Therapeutics position peaked at $595K in Q4 2021.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.